Cargando…

Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage

AIM: The purpose of this study was to evaluate the extended physicochemical and biological stability of Sandoz Rixathon®/Riximyo® (SDZ-RTX) after exposure to out-of-fridge (OOF) conditions. MATERIALS AND METHODS: The impact of the short-term temperature excursion on stability parameters of SDZ-RTX w...

Descripción completa

Detalles Bibliográficos
Autores principales: Borišek, Roman, Mischo, André, Šmid, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433506/
https://www.ncbi.nlm.nih.gov/pubmed/35933639
http://dx.doi.org/10.1007/s40268-022-00393-4
_version_ 1784780636015296512
author Borišek, Roman
Mischo, André
Šmid, Ida
author_facet Borišek, Roman
Mischo, André
Šmid, Ida
author_sort Borišek, Roman
collection PubMed
description AIM: The purpose of this study was to evaluate the extended physicochemical and biological stability of Sandoz Rixathon®/Riximyo® (SDZ-RTX) after exposure to out-of-fridge (OOF) conditions. MATERIALS AND METHODS: The impact of the short-term temperature excursion on stability parameters of SDZ-RTX was simulated by subsequently exposing the three batches of SDZ-RTX (100 and 500 mg) to OOF conditions, (I) 25 ± 2 °C/60 ± 5% relative humidity (RH) and (II) 30 ± 2 °C/65 ± 5% RH, for up to 21 days after more than the claimed 36-month shelf-life storage in long-term conditions (5 ± 3 °C). Analytical methods used included the cation exchange chromatography (CEX), size exclusion chromatography (SEC), and non-reducing capillary electrophoresis-sodium dodecyl sulfate (nrCE-SDS), as well as biological activity by complement-dependent cytotoxicity (CDC)-bioactivity as well as further methods, for example, related to identity and pharmacopoeia test methods. RESULTS: No notable changes were observed across all batches with respect to identity (charge and primary structure), pharmaceutical tests (clarity, visible and subvisible particles analytics, container appearance, degree of coloration, pH, osmolality, extractable volume, and container closure integrity testing), protein content by UV and microbiological parameters (sterility and bacterial endotoxins) under both OOF conditions. Only minor changes were observed for parameters evaluated via SEC, CEX, and nrCE-SDS. For potency (CDC-bioactivity) only one of the batches showed a relevant change. Even for these stability-indicating test methods, all analyzed parameters complied with the shelf-life specifications. CONCLUSION: SDZ-RTX is safe for use even under worst-case conditions, for example, after subjecting it for up to 21 days at OOF conditions (25 ± 2 °C/60 ± 5% RH or 30 ± 2 °C/65 ± 5% RH) after the batches had reached an age that was already beyond the claimed shelf-life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40268-022-00393-4.
format Online
Article
Text
id pubmed-9433506
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-94335062022-09-02 Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage Borišek, Roman Mischo, André Šmid, Ida Drugs R D Original Research Article AIM: The purpose of this study was to evaluate the extended physicochemical and biological stability of Sandoz Rixathon®/Riximyo® (SDZ-RTX) after exposure to out-of-fridge (OOF) conditions. MATERIALS AND METHODS: The impact of the short-term temperature excursion on stability parameters of SDZ-RTX was simulated by subsequently exposing the three batches of SDZ-RTX (100 and 500 mg) to OOF conditions, (I) 25 ± 2 °C/60 ± 5% relative humidity (RH) and (II) 30 ± 2 °C/65 ± 5% RH, for up to 21 days after more than the claimed 36-month shelf-life storage in long-term conditions (5 ± 3 °C). Analytical methods used included the cation exchange chromatography (CEX), size exclusion chromatography (SEC), and non-reducing capillary electrophoresis-sodium dodecyl sulfate (nrCE-SDS), as well as biological activity by complement-dependent cytotoxicity (CDC)-bioactivity as well as further methods, for example, related to identity and pharmacopoeia test methods. RESULTS: No notable changes were observed across all batches with respect to identity (charge and primary structure), pharmaceutical tests (clarity, visible and subvisible particles analytics, container appearance, degree of coloration, pH, osmolality, extractable volume, and container closure integrity testing), protein content by UV and microbiological parameters (sterility and bacterial endotoxins) under both OOF conditions. Only minor changes were observed for parameters evaluated via SEC, CEX, and nrCE-SDS. For potency (CDC-bioactivity) only one of the batches showed a relevant change. Even for these stability-indicating test methods, all analyzed parameters complied with the shelf-life specifications. CONCLUSION: SDZ-RTX is safe for use even under worst-case conditions, for example, after subjecting it for up to 21 days at OOF conditions (25 ± 2 °C/60 ± 5% RH or 30 ± 2 °C/65 ± 5% RH) after the batches had reached an age that was already beyond the claimed shelf-life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40268-022-00393-4. Springer International Publishing 2022-08-07 2022-09 /pmc/articles/PMC9433506/ /pubmed/35933639 http://dx.doi.org/10.1007/s40268-022-00393-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Borišek, Roman
Mischo, André
Šmid, Ida
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title_full Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title_fullStr Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title_full_unstemmed Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title_short Study of the Stability of Sandoz Rituximab Biosimilar Rixathon(®)/Riximyo(®) When Subjected for up to 21 Days to Ambient Storage
title_sort study of the stability of sandoz rituximab biosimilar rixathon(®)/riximyo(®) when subjected for up to 21 days to ambient storage
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433506/
https://www.ncbi.nlm.nih.gov/pubmed/35933639
http://dx.doi.org/10.1007/s40268-022-00393-4
work_keys_str_mv AT borisekroman studyofthestabilityofsandozrituximabbiosimilarrixathonriximyowhensubjectedforupto21daystoambientstorage
AT mischoandre studyofthestabilityofsandozrituximabbiosimilarrixathonriximyowhensubjectedforupto21daystoambientstorage
AT smidida studyofthestabilityofsandozrituximabbiosimilarrixathonriximyowhensubjectedforupto21daystoambientstorage